Oral Administration of a Dual Analog of Two Myasthenogenic T Cell Epitopes Down-Regulates Experimental Autoimmune Myasthenia Gravis in Mice

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.040554597
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

Immunosuppression of Experimental Autoimmune Myasthenia Gravis by Mycophenolate Mofetil

Journal of Neuroimmunology
AllergyImmunologyNeurology
2008English

Complicating Autoimmune Diseases in Myasthenia Gravis: A Review

Autoimmunity
AllergyImmunology
2015English

Ephedrine Treatment for Autoimmune Myasthenia Gravis

Neuromuscular Disorders
Child HealthNeurologyPediatricsPerinatologyGenetics
2017English

Differential RNA Expression Profile of Skeletal Muscle Induced by Experimental Autoimmune Myasthenia Gravis in Rats

Frontiers in Physiology
Physiology
2016English

Administration of Bifidobacterium and Lactobacillus Strains Modulates Experimental Myasthenia Gravis and Experimental Encephalomyelitis in Lewis Rats

Oncotarget
Oncology
2018English

Absence of IL-4 Facilitates the Development of Chronic Autoimmune Myasthenia Gravis in C57bl/6 Mice

Journal of Immunology
AllergyImmunology
2003English

New Pathways and Therapeutic Targets in Autoimmune Myasthenia Gravis

Journal of Neuromuscular Diseases
Neurology
2018English

Autoimmune Myasthenia Gravis: Emerging Clinical and Biological Heterogeneity

The Lancet Neurology
Neurology
2009English

Multimerized T Cell Epitopes Protect From Experimental Autoimmune Diabetes by Inducing Dominant Tolerance

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy